Sleep Review’s webinar Insomnia Therapies, from CBT-I to Pharmaceuticals is now available for on-demand viewing. In the hour-long free webcast, Sleep Review editor Sree Roy and three expert presenters delved into the various therapeutic choices for this common sleep disorder. During the second 30 minutes, the presenters answered audience questions.

Watch the webinar to learn:

  • The scope of the insomnia problem in the United States
  • Advantages and disadvantages of CBT-I
  • Advantages and disadvantages of pharmaceuticals

Insomnia Therapies, from CBT-I to Pharmaceuticals from Allied 360 on Vimeo.


Russell Rosenberg, PhD, DABSM, is the founder and director of the Atlanta School of Sleep Medicine and Technology. A clinical psychologist and board certified sleep specialist, Rosenberg lectures and teaches internationally on a range of sleep medicine topics. His areas of expertise include insomnia and disorders of excessive daytime sleepiness. In addition to teaching, he is actively involved in clinical research at NeuroTrials Research Inc.

Emerson Wickwire, PhD, is director of the Insomnia Program and assistant professor of Psychiatry and Medicine at the University of Maryland School of Medicine. He is a recognized expert in the nondrug treatments of sleep disorders and leveraging technology to improve patient care in medical and organizational settings. Wickwire is a member of Sleep Review’s editorial advisory board.

David N. Neubauer, MD, is associate professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine and associate director of the Johns Hopkins Sleep Disorders Center. He is a fellow of the American Academy of Sleep Medicine and the American Psychiatric Association. He is the author of the Understanding Sleeplessness: Perspective on Insomnia published by the Johns Hopkins University Press.

The webinar originally aired May 13, 2015.